HUP0202516A3 - Methods for crystallization of n-(1-(s)-ethoxycarbonyl-3-phenylpropyl)-l-alanine n-carboxyanhydride - Google Patents

Methods for crystallization of n-(1-(s)-ethoxycarbonyl-3-phenylpropyl)-l-alanine n-carboxyanhydride

Info

Publication number
HUP0202516A3
HUP0202516A3 HU0202516A HUP0202516A HUP0202516A3 HU P0202516 A3 HUP0202516 A3 HU P0202516A3 HU 0202516 A HU0202516 A HU 0202516A HU P0202516 A HUP0202516 A HU P0202516A HU P0202516 A3 HUP0202516 A3 HU P0202516A3
Authority
HU
Hungary
Prior art keywords
carboxyanhydride
phenylpropyl
ethoxycarbonyl
alanine
crystallization
Prior art date
Application number
HU0202516A
Other languages
English (en)
Original Assignee
Kaneka Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kaneka Corp filed Critical Kaneka Corp
Publication of HUP0202516A2 publication Critical patent/HUP0202516A2/hu
Publication of HUP0202516A3 publication Critical patent/HUP0202516A3/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/44Two oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
HU0202516A 2000-05-15 2001-05-15 Methods for crystallization of n-(1-(s)-ethoxycarbonyl-3-phenylpropyl)-l-alanine n-carboxyanhydride HUP0202516A3 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2000141717 2000-05-15
JP2000330339 2000-10-30
JP2000352892 2000-11-20
PCT/JP2001/004059 WO2001087858A1 (fr) 2000-05-15 2001-05-15 Procedes de cristallisation d'un n-carboxyanhydride de n-(1(s)-ethoxycarbonyl-3-phenylpropyl)-l-alanine

Publications (2)

Publication Number Publication Date
HUP0202516A2 HUP0202516A2 (hu) 2003-01-28
HUP0202516A3 true HUP0202516A3 (en) 2003-04-28

Family

ID=27343377

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0202516A HUP0202516A3 (en) 2000-05-15 2001-05-15 Methods for crystallization of n-(1-(s)-ethoxycarbonyl-3-phenylpropyl)-l-alanine n-carboxyanhydride

Country Status (17)

Country Link
US (1) US6784310B2 (hu)
EP (1) EP1283204B1 (hu)
JP (1) JP4149706B2 (hu)
KR (1) KR100527648B1 (hu)
CN (1) CN1184213C (hu)
AT (1) ATE423106T1 (hu)
AU (1) AU5675801A (hu)
CZ (1) CZ2002532A3 (hu)
DE (1) DE60137686D1 (hu)
ES (1) ES2320413T3 (hu)
HR (1) HRP20020122A2 (hu)
HU (1) HUP0202516A3 (hu)
IS (1) IS6224A (hu)
PL (1) PL351841A1 (hu)
SI (1) SI20817A (hu)
TW (1) TW527351B (hu)
WO (1) WO2001087858A1 (hu)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1659145B2 (en) 2003-08-29 2016-06-08 Sekisui Plastics Co., Ltd. Pre-expanded particle of olefin-modified polystyrene resin, process for producing the same, and molded foam
JP4852282B2 (ja) * 2005-08-29 2012-01-11 保土谷化学工業株式会社 N−カルボン酸無水物の製造方法
CN101293887A (zh) * 2007-04-26 2008-10-29 中国科学院福建物质结构研究所 一种高纯度环状硫酸酯的纯化方法
JP2011016790A (ja) 2009-06-08 2011-01-27 Sumitomo Chemical Co Ltd ピラゾリノン誘導体の精製方法
WO2014202659A1 (en) 2013-06-21 2014-12-24 Sanofi-Aventis Deutschland Gmbh Process for the preparation of amides of n-[1-(s)-(ethoxycarbonyl)-3-phenylpropyl]-l-alanine
CN112912369A (zh) * 2018-09-28 2021-06-04 隆萨有限公司 制备n-羧基内酸酐的方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4496542A (en) * 1981-03-30 1985-01-29 Usv Pharmaceutical Corporation N-substituted-amido-amino acids
US4831184A (en) * 1981-03-30 1989-05-16 Rorer Pharmaceutical Corporation N-substituted-amido-amino acids
JPS6248696A (ja) * 1985-08-27 1987-03-03 Kanegafuchi Chem Ind Co Ltd N−〔1(s)−エトキシカルボニル−3−フエニルプロピル〕−l−アラニル−l−プロリンの製造法
SI9200213A (en) * 1992-09-16 1994-03-31 Krka Process for preparing alkyl-l-alanil-l-proline derivates
PL177163B1 (pl) 1992-11-13 1999-09-30 Du Pont Sposób wytwarzania 2,4-oksazolidynodionów oraz nowe triazolokarboksylany i imidazolokarboksylany
IN184759B (hu) * 1997-07-22 2000-09-23 Kaneka Corp
JP4505917B2 (ja) * 1999-01-22 2010-07-21 田辺三菱製薬株式会社 新規微生物およびそれを用いるl−アミノ酸の製法

Also Published As

Publication number Publication date
EP1283204A4 (en) 2007-09-05
TW527351B (en) 2003-04-11
HUP0202516A2 (hu) 2003-01-28
US6784310B2 (en) 2004-08-31
SI20817A (sl) 2002-08-31
EP1283204B1 (en) 2009-02-18
JP4149706B2 (ja) 2008-09-17
EP1283204A1 (en) 2003-02-12
CZ2002532A3 (cs) 2002-05-15
IS6224A (is) 2002-01-09
AU5675801A (en) 2001-11-26
ES2320413T3 (es) 2009-05-22
ATE423106T1 (de) 2009-03-15
KR100527648B1 (ko) 2005-11-09
PL351841A1 (en) 2003-06-16
US20020137944A1 (en) 2002-09-26
CN1380881A (zh) 2002-11-20
WO2001087858A1 (fr) 2001-11-22
KR20020038689A (ko) 2002-05-23
HRP20020122A2 (en) 2003-04-30
CN1184213C (zh) 2005-01-12
DE60137686D1 (de) 2009-04-02

Similar Documents

Publication Publication Date Title
PL372626A1 (en) Peptide derivatives comprising thiazepine group for the treatment of hyperlipidemic conditions
PT1254124E (pt) Nitrilos dipeptídicos inibidores de catepsina k
IL129555A (en) Pharmaceutical compositions containing n-(oxoacetyl)-amino acid amide derivatives for stimulating neurite growth
AU2003251411A8 (en) Stop-cock suture clamping system
HK1052502A1 (en) Hydrochloride salts of 5-Ä4-Ä2-(N-methyl-n-2-pyridyl) amino) ethoxyÜbenzylÜthiazolidine-2,4-dione
HK1072265A1 (en) Selective dipeptide inhibitors of kallikrein
ZA200210092B (en) alpha crystalline form of perindopril tert-butylamine salt.
IL159808A0 (en) N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds
AP2002002630A0 (en) Method for synthesis of perindopril and its pharmaceutically acceptable salts
IL141767A0 (en) Use of heteroaryl substituted n- (indole-2-carbonyl-) amides for treatment of infection
ITMI20031696A1 (it) Distributore di coppia per veicoli nonche' procedimento
AU2003274462A8 (en) N-(indole-2-carbonyl) amides as anti-diabetic agents
IL157643A0 (en) Peptide deformylase inhibitors
PL339211A1 (en) Basic salts of n-[n-(3,3-dimethylbutyl)-l-alpha-aspartil]-l-phenylamine 1-methyl ester
HUP0202516A3 (en) Methods for crystallization of n-(1-(s)-ethoxycarbonyl-3-phenylpropyl)-l-alanine n-carboxyanhydride
AU5046701A (en) Method for synthesis of N-((S)-1-carboxybutyl)-(S)-alanine esters and use in synthesis of perindopril
AU4843301A (en) Novel method for synthesis of N-((S)-1-carboxybutyl)-(S)-alanine esters and use in synthesis of perindopril
AU2001248433A1 (en) Novel method for synthesis of N-((S)-1-carboxybutyl)-(S)-alanine esters and use in synthesis of perindopril
IL152638A0 (en) Peptide deformylase inhibitors
HUP0105427A3 (en) Method for drying protein crystals
DE60001787D1 (de) Verfahren zur Herstellung von N-Acyl-Aminosäureamiden
HUP0303176A3 (en) Purification method of n-(1(s)-ethoxycarbonyl-3-phenylpropyl)-l-alanine
IL151884A0 (en) Peptide deformylase inhibitors
HUP0004149A3 (en) Method for crystallizing maleic acid salt of n-(1(s)-ethoxycarbonyl-3-phenylpropyl)-l-alanyl-l-proline
AU2002238954A1 (en) Purification method of n-(1(s)-ethoxycarbonyl-3-phenylpropyl)-l-alanine

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees